SCHEMBL379764

SCHEMBL379764

O=C(O)CN(CCO)CCN(CC(=O)O)CC(=O)O.[NaH].[NaH].[NaH]

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.75
TDP1 Q9NUW8 2/20 0.75
KDM4E B2RXH2 2/20 0.75
BLM P54132 2/20 0.75
PMP22 Q01453 2/20 0.75
LMNA P02545 2/20 0.75
TSHR P16473 2/20 0.75
CYP2C19 P33261 2/20 0.75
CHRM2 P08172 1/20 0.75
ADRA2A P08913 1/20 0.75
DRD1 P21728 1/20 0.75
SLC6A2 P23975 1/20 0.75
SLC6A4 P31645 1/20 0.75
ADRA1A P35348 1/20 0.75
DRD3 P35462 1/20 0.75
SLC6A3 Q01959 1/20 0.75
HRH3 Q9Y5N1 1/20 0.75
EYA2 O00167 1/20 0.70
APP P05067 1/20 0.70
ACE P12821 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Edetic Acid SCHEMBL5013130 1.00 ALOX15 (0.75) ALOX15TDP1KDM4EBLMPMP22
SCHEMBL16033770 1.00 ALOX15 (0.75) ALOX15TDP1KDM4EBLMPMP22
SCHEMBL16035499 1.00 ALOX15 (0.75) ALOX15TDP1KDM4EBLMPMP22
SCHEMBL4018392 1.00 ALOX15 (0.75) ALOX15TDP1KDM4EBLMPMP22
Water SCHEMBL28235613 0.98 TDP1 (0.71) ALOX15TDP1KDM4EBLMPMP22
Edetic Acid SCHEMBL7943086 0.98 TDP1 (0.71) ALOX15TDP1KDM4EBLMPMP22
SCHEMBL20680052 0.98 ALOX15 (0.71) ALOX15TDP1KDM4EBLMPMP22
Water SCHEMBL9900442 0.98 TDP1 (0.71) ALOX15TDP1KDM4EBLMPMP22
SCHEMBL24758890 0.97 ALOX15 (0.79) ALOX15TDP1KDM4EBLMPMP22
Edetic Acid SCHEMBL1768177 0.97 ALOX15 (0.79) ALOX15TDP1KDM4EBLMPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1081 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4593966-A2 HAIR DEMINERALIZER COMPOSITION, METHODS AND USES THEREOF K18, Inc. (US) 2025-08-06 EP claimed
WO-2025082731-A1 INTRANASAL FORMULATIONS FOR TREATING OBSTRUCTIVE SLEEP APNEA MOSANNA THERAPEUTICS AG (CH) 2025-04-24 WO claimed
WO-2025068591-A1 INTRANASAL FORMULATIONS FOR TREATING OBSTRUCTIVE SLEEP APNEA MOSANNA THERAPEUTICS AG (CH) 2025-04-03 WO claimed
WO-2025068792-A2 EXTRACTANT COMPOSITIONS PRECISION PLANTING LLC (US) 2025-04-03 WO claimed
US-12263238-B2 Styling composition for providing various advantageous properties to the hair L'OREAL (FR) 2025-04-01 US claimed
US-20240342070-A1 Topical Compositions and Formulations with Multifunctional Actions, Including Activity Against Parasites BIOSAFE TECHNOLOGIES, INC. (US) 2024-10-17 US claimed
EP-4384138-A1 TOPICAL COMPOSITIONS AND FORMULATIONS WITH MULTIFUNCTIONAL ACTIONS, INCLUDING ACTIVITY AGAINST PARASITES BioSafe Technologies, Inc. (US) 2024-06-19 EP claimed
US-20240122835-A1 NEW STYLING COMPOSITION FOR PROVIDING VARIOUS ADVANTAGEOUS PROPERTIES TO THE HAIR L'OREAL (FR) 2024-04-18 US claimed
US-20240108560-A1 HAIR DEMINERALIZER COMPOSITION, METHODS AND USES THEREOF K18, INC. 2024-04-04 US claimed
WO-2024073683-A2 HAIR DEMINERALIZER COMPOSITION, METHODS AND USES THEREOF K18, INC. (US) 2024-04-04 WO claimed
WO-2008152444-A2 FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS FOAMIX LTD. (US) 2008-12-18 WO claimed
EP-1998825-A2 ANTIMICROBIAL COMPOSITIONS AND METHODS FOR LOCKING CATHETERS Becton, Dickinson and Company, Wagner, Jaconda (US) 2008-12-10 EP claimed
US-20080206159-A1 Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions FOAMIX LTD. (IL) 2008-08-28 US claimed
WO-2007100776-A2 ANTIMICROBIAL COMPOSITIONS AND METHODS FOR LOCKING CATHETERS BECTON, DICKINSON AND COMPANY (US) 2007-09-07 WO claimed
US-20070202177-A1 Antimicrobial Compositions and Methods for Locking Catheters BECTON, DICKINSON AND COMPANY (US) 2007-08-30 US claimed
US-20050123502-A1 Nicotine containing oral compositions SMITHKLINE BEECHAM CORPORATION 2005-06-09 US claimed
EP-1245247-A1 Biocidal locks Biolink Corporation (US) 2002-10-02 EP claimed
US-6350251-B1 Biocidal locks BIOLINK CORPORATION 2002-02-26 US claimed
US-5925366-A PERMEATION/BINDING AGENT, THIO CROSSLINKING AGENT, AND CHELATE COMPOUND REVLON CONSUMER PRODUCTS CORPORATION (US) 1999-07-20 US claimed
WO-1998006376-A1 NAIL STRENGTHENING COMPOSITIONS AND A METHOD FOR STRENGTHENING NAILS REVLON CONSUMER PRODUCTS CORPORATION (US) 1998-02-19 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240122835-A1 NEW STYLING COMPOSITION FOR PROVIDING VARIOUS ADVANTAGEOUS PROPERTIES TO THE HAIR SUCLG1, FSCN1, SHH ALOX15 4167/4885TDP1 3753/4885KDM4E 2761/4885
US-20080206159-A1 Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions CUTA, SLTM, SMO ALOX15 420/4885TDP1 4447/4885KDM4E 4432/4885
US-12263238-B2 Styling composition for providing various advantageous properties to the hair SUCLG1, FSCN1, SHH ALOX15 4052/4885TDP1 3421/4885KDM4E 2244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.